Immune checkpoint inhibitors and chemotherapy versus chemotherapy for early triple-negative breast cancer (protocol)

Tools

Gao, Ya, Liu, M, Liu, L, Zhang, J, Song, F and Tian, J (2022) Immune checkpoint inhibitors and chemotherapy versus chemotherapy for early triple-negative breast cancer (protocol). Cochrane Database of Systematic Reviews, 2022 (9). ISSN 1361-6137

[thumbnail of Gao_et_al-2022-Cochrane_Database_of_Systematic_Reviews]
Preview
 PDF (Gao_et_al-2022-Cochrane_Database_of_Systematic_Reviews) - Published Version
Download (183kB) | Preview

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the efficacy and safety of PD-1 inhibitors or PD-L1 inhibitors plus chemotherapy compared with chemotherapy for people with early triple-negative breast cancer.

Item Type: Article
Uncontrolled Keywords: pharmacology (medical),sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2700/2736
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023)
Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care
Faculty of Medicine and Health Sciences > Research Groups > Epidemiology and Public Health
Faculty of Medicine and Health Sciences > Research Centres > Population Health (former - to 2025)
Faculty of Medicine and Health Sciences > Research Centres > Public Health
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 08 Nov 2022 17:30
Last Modified: 11 Oct 2025 22:31
URI: https://ueaeprints.uea.ac.uk/id/eprint/89710
DOI: 10.1002/14651858.CD015072

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item